Publicaciones - CARDIOLOGIA CLINICA Y EXPERIMENTAL

Cargando...

Ding WY, Potpara TS, Blomstrom-Lundqvist C, Boriani G, Marin F, Fauchier L, Lip GYH; ESC-EHRA EORP-AF Long-Term General Registry Investigators. Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry. Eur J Clin Invest. 2022 Jun;52(6):e13745. doi: 10.1111/eci.13745. Epub 2022 Jan 17. PubMed PMID: 35000206; PubMed Central PMCID: PMC9287022.

AÑO: 2022; IF: 5.5

35000206

Sanmartin Fernandez M, Anguita Sanchez M, Arribas F, Baron-Esquivias G, Barrios V, Cosin-Sales J, Esteve-Pastor MA, Freixa-Pamias R, Lekuona I, Perez-Cabeza AI, Urena I, Vazquez Rodriguez JM, Rafols Priu C, Marin F. Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study. Cardiol J. 2022;29(4):601-609. doi: 10.5603/CJ.a2022.0044. Epub 2022 May 27. PubMed PMID: 35621092; PubMed Central PMCID: PMC9273239.

AÑO: 2022; IF: 2.9

35621092

Marin F, Fernandez MS, Lekuona I, Arribas F, Baron-Esquivias G, Barrios V, Cosin-Sales J, Freixa-Pamias R, Masjuan J, Perez-Cabeza AI, Schilling VR, Vazquez Rodriguez JM, Priu CR, Sanchez MA. Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries. J Comp Eff Res. 2022 Nov;11(16):1173-1184. doi: 10.2217/cer-2022-0111. Epub 2022 Sep 23. PubMed PMID: 36148923.

AÑO: 2022; IF: 2.1

36148923

Nadarajah R, Ludman P, Appelman Y, Brugaletta S, Budaj A, Bueno H, Huber K, Kunadian V, Leonardi S, Lettino M, Milasinovic D, Gale CP; NSTEMI Investigators. Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry. Eur Heart J Qual Care Clin Outcomes. 2022 Dec 13;9(1):8-15. doi: 10.1093/ehjqcco/qcac067. PubMed PMID: 36259751.

AÑO: 2022; IF: 5.2

36259751

SEC Working Group for the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice and SEC Guidelines Committee. Comments on the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Rev Esp Cardiol (Engl Ed). 2022 May;75(5):364-369. doi: 10.1016/j.rec.2021.10.023. Epub 2022 Feb 11. No abstract available. English, Spanish. PubMed PMID: 35165071.

AÑO: 2022; IF: 5.9

35165071

< Anterior Siguiente >

Publicaciones - CARDIOLOGIA CLINICA Y EXPERIMENTAL

Instituto de Investigación Sanitaria Acreditado

CARDIOLOGIA CLINICA Y EXPERIMENTAL